Inhibikase Therapeutics
Develops IKT-001 as a clinical-stage therapy for pulmonary arterial hypertension.
$2.41
After-hours close−0.00 (−0.21%)
At close$2.42(−2.23%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.11 | — | — |
| Aug 2026 | −$0.11 | −$0.11 | −2.3% |
| May 2026 | −$0.10 | −$0.10 | 0.0% |
| Mar 2026 | −$0.12 | −$0.09 | +25.0% |
| Nov 2025 | −$0.13 | −$0.13 | 0.0% |
The latest year is open to everyone — the 30 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| Mar 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Sep 2020 | |||
| Jun 2020 | |||
| Mar 2020 | |||
| Dec 2019 | |||
| Sep 2019 | |||
| Jun 2019 | |||
| Mar 2019 | |||
| Dec 2018 | |||
| Mar 2018 | |||
| Dec 2017 | |||
| Mar 2017 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 13, 2026 | −$0.11 | — | — | — | — | — |
| Aug 11, 2026 | −$0.11 | −$0.11 | −2.3% | — | — | — |
| May 12, 2026 | −$0.10 | −$0.10 | 0.0% | — | — | — |
| Mar 26, 2026 | −$0.12 | −$0.09 | +25.0% | — | — | — |
| Nov 14, 2025 | −$0.13 | −$0.13 | 0.0% | — | — | — |
The latest year is open to everyone — the 30 quarters behind it read with an account. Sign in | ||||||
| Aug 14, 2025 | ||||||
| May 14, 2025 | ||||||
| Mar 26, 2025 | ||||||
| Nov 14, 2024 | ||||||
| Aug 14, 2024 | ||||||
| May 15, 2024 | ||||||
| Mar 27, 2024 | ||||||
| Nov 14, 2023 | ||||||
| Aug 14, 2023 | ||||||
| Mar 31, 2023 | ||||||
| Mar 30, 2023 | ||||||
| Nov 14, 2022 | ||||||
| Aug 12, 2022 | ||||||
| May 16, 2022 | ||||||
| Mar 31, 2022 | ||||||
| Nov 15, 2021 | ||||||
| Aug 16, 2021 | ||||||
| May 17, 2021 | ||||||
| Mar 31, 2021 | ||||||
| Sep 30, 2020 | ||||||
| Jun 30, 2020 | ||||||
| Mar 31, 2020 | ||||||
| Dec 31, 2019 | ||||||
| Sep 30, 2019 | ||||||
| Jun 30, 2019 | ||||||
| Mar 31, 2019 | ||||||
| Dec 31, 2018 | ||||||
| Mar 31, 2018 | ||||||
| Dec 31, 2017 | ||||||
| Mar 31, 2017 | ||||||